Literature DB >> 22045586

Vibriocidal assays to determine the antibody titer of patient sera samples.

Mike S Son1, Ronald K Taylor.   

Abstract

The vibriocidal titer assay can be used to detect antibodies against Vibrio cholerae in serum samples, serving as an indicator of prior infection and potential protection against cholera. The assay can be utilized in research and clinical settings to test the effectiveness of vaccines, and also in epidemiological studies relevant to cholera transmission and surveillance. This unit outlines the steps involved in conducting an easily interpreted colorimetric vibriocidal titer assay with a relatively short turnaround time for results of around 8 hr, with final result observations in 24 hr. The assay can also be easily scaled up or down to accommodate as many or as few serum samples available and is not V. cholerae strain specific.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22045586      PMCID： PMC3228410          DOI： 10.1002/9780471729259.mc06a03s23

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  8 in total

1.  Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.

Authors:  Stephen R Attridge; Camilla Johansson; Dang D Trach; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  A semi-automated vibriocidal assay for improved measurement of cholera vaccine-induced immune responses.

Authors:  Jae Seung Yang; Hye Jin Kim; Cheol-Heui Yun; Seok-Seong Kang; Jintaek Im; Hak-Sung Kim; Seung Hyun Han
Journal:  J Microbiol Methods       Date:  2007-08-31       Impact factor: 2.363

3.  Quantitation of vibriocidal antibodies using agar plague techniques.

Authors:  J Holmgren; A M Svennerholm; O Ouchterlony
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

4.  Susceptibility of Vibrio cholerae O139 to antibody-dependent, complement-mediated bacteriolysis.

Authors:  S R Attridge; F Qadri; M J Albert; P A Manning
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

5.  Induction of protective immunity by synthetic Vibrio cholerae hexasaccharide derived from V. cholerae O1 Ogawa lipopolysaccharide bound to a protein carrier.

Authors:  Anatoly Chernyak; Seiichi Kondo; Terri K Wade; Michael D Meeks; Pedro M Alzari; Jean-Michel Fournier; Ronald K Taylor; Pavol Kovác; William F Wade
Journal:  J Infect Dis       Date:  2002-03-19       Impact factor: 5.226

6.  Characterization of a novel protective monoclonal antibody that recognizes an epitope common to Vibrio cholerae Ogawa and Inaba serotypes.

Authors:  Madushini N Dharmasena; Shelly J Krebs; Ronald K Taylor
Journal:  Microbiology (Reading)       Date:  2009-04-23       Impact factor: 2.777

7.  A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139.

Authors:  Alain Boutonnier; Bruno Dassy; Rémy Duménil; Alain Guénolé; Maherisoa Ratsitorahina; René Migliani; Jean-Michel Fournier
Journal:  J Microbiol Methods       Date:  2003-12       Impact factor: 2.363

8.  Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique.

Authors:  A S Benenson; A Saad; W H Mosley
Journal:  Bull World Health Organ       Date:  1968       Impact factor: 9.408
  8 in total
  9 in total

1.  Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide.

Authors:  Kara J Levinson; Samantha R Giffen; Michael H Pauly; Do H Kim; Ognian Bohorov; Natasha Bohorova; Kevin J Whaley; Larry Zeitlin; Nicholas J Mantis
Journal:  J Immunol Methods       Date:  2015-04-09       Impact factor: 2.303

2.  Increasing the High Throughput of a Luminescence-Based Serum Bactericidal Assay (L-SBA).

Authors:  Maria Grazia Aruta; Martina Carducci; Francesca Micoli; Francesca Necchi; Omar Rossi
Journal:  BioTech (Basel)       Date:  2021-09-18

3.  Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.

Authors:  Bolutife Fakoya; Brandon Sit; Matthew K Waldor
Journal:  J Bacteriol       Date:  2020-11-19       Impact factor: 3.490

4.  Nontoxigenic Vibrio cholerae Challenge Strains for Evaluating Vaccine Efficacy and Inferring Mechanisms of Protection.

Authors:  Bolutife Fakoya; Karthik Hullahalli; Daniel H F Rubin; Deborah R Leitner; Roma Chilengi; David A Sack; Matthew K Waldor
Journal:  mBio       Date:  2022-04-07       Impact factor: 7.786

5.  Development of a high-throughput method to evaluate serum bactericidal activity using bacterial ATP measurement as survival readout.

Authors:  Francesca Necchi; Allan Saul; Simona Rondini
Journal:  PLoS One       Date:  2017-02-13       Impact factor: 3.240

6.  Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Authors:  Kamrul Islam; Motaher Hossain; Meagan Kelly; Leslie M Mayo Smith; Richelle C Charles; Taufiqur Rahman Bhuiyan; Pavol Kováč; Peng Xu; Regina C LaRocque; Stephen B Calderwood; Jakub K Simon; Wilbur H Chen; Douglas Haney; Michael Lock; Caroline E Lyon; Beth D Kirkpatrick; Mitchell Cohen; Myron M Levine; Marc Gurwith; Jason B Harris; Firdausi Qadri; Edward T Ryan
Journal:  PLoS Negl Trop Dis       Date:  2018-04-06

7.  Immunogenicity and waning immunity from the oral cholera vaccine (Shanchol™) in adults residing in Lukanga Swamps of Zambia.

Authors:  Harriet Ng Ombe; Michelo Simuyandi; John Mwaba; Charlie Chaluma Luchen; Peter Alabi; Obvious Nchimunya Chilyabanyama; Cynthia Mubanga; Luiza Miyanda Hatyoka; Mutinta Muchimba; Samuel Bosomprah; Roma Chilengi; Geoffrey Kwenda; Caroline Cleopatra Chisenga
Journal:  PLoS One       Date:  2022-01-05       Impact factor: 3.240

8.  Dried Blood Spots for Measuring Vibrio cholerae-specific Immune Responses.

Authors:  Anita S Iyer; Andrew S Azman; Malika Bouhenia; Lul O Deng; Cole P Anderson; Michael Graves; Pavol Kováč; Peng Xu; Edward T Ryan; Jason B Harris; David A Sack; Francisco J Luquero; Daniel T Leung
Journal:  PLoS Negl Trop Dis       Date:  2018-01-29

9.  A dysbiotic gut microbiome suppresses antibody mediated-protection against Vibrio cholerae.

Authors:  John C Macbeth; Rui Liu; Salma Alavi; Ansel Hsiao
Journal:  iScience       Date:  2021-11-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.